Court Denies Motion to Dismiss BRCA Patent Suit Against Myriad, Others | GenomeWeb

NEW YORK (GenomeWeb News) – A US district court has denied a motion by the US Patent and Trademark Office, Myriad Genetics, and the University of Utah Research Foundation to dismiss a lawsuit brought against them challenging the legality and constitutionality of BRCA gene patents owned by the University of Utah and exclusively licensed to Myriad.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.